T Cell Activation and Clonal Selection
T Cell Types and Functions
Cytotoxic T Cells-mediated Immune Response
Antigen Presenting Cells
Antigens Involved in Adaptive Immunity
Diversity of Antigen Receptors
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 18, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
Julie Tabiasco1, Estelle Devêvre, Nathalie Rufer
1Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Lausanne Branch, University Hospital (Centre Hospitalier Universitaire Vaudois), Avenue Pierre-Decker 4, 1005 Lausanne, Switzerland.
Toll-like receptor 3 (TLR3) is expressed on effector CD8+ T cells, enhancing their IFN-gamma production. This suggests TLR3 ligands may directly boost adaptive immunity and serve as immunotherapy adjuvants.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: